Biology; Chemistry and chemical biology; Chemical and biological engineering; Biomedical engineering
In Copyright : this Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). https://rightsstatements.org/page/InC/1.0/;
Synthesis of heparin immobilized-magnetically addressable cellulose nanofibers for biomedical applications L. Hou, W.M. R. Udangawa, A. Pochiraju, W. Dong, Y. Zheng, R. J. Linhardt, T. Simmons, ACS Biomaterials Science & Engineering, 2, 1905−1913, 2016.
Magnetically responsive heparin-immobilized cellulose nanofiber composites were synthesized by wet-wet electrospinning from a nonvolatile, room-temperature ionic liquid (RTIL), 1-methyl-3-methylimidazolium acetate ([EMIM][Ac]), into an aqueous coagulation bath. Superparamagnetic magnetite (Fe3O4) nanoparticles were incorporated into the fibers to enable the manipulation of both dry and wet nanofiber membranes with an external magnetic field. Three synthetic routes were developed to prepare three distinct types of nanocomposite fibers: cellulose-Fe3O4–heparin monofilament fibers, cellulose-Fe3O4–heparin core–shell fibers with heparin covalently immobilized on the fiber surface, and cellulose -Fe3O4 core–shell fibers with heparin physically immobilized on the fiber surface. These nanocomposite fibers were characterized by electron microscopy to confirm their coaxial structure and the fiber dimensions (fiber diameter 0.2–2.0 μm with 0.1–1.1 μm core diameter). Thermogravimetric analysis, liquid chromatography–mass spectrometry, Fourier transform infrared and X-ray diffraction spectroscopy provided detailed compositional analysis for these nanocomposite fibers, confirming the presence of each component and the surface accessibility of the heparin. The anticoagulant activity of immobilized heparin on the nanocomposite fiber surfaces was evaluated and confirmed by antifactor Xa and antifactor IIa assays.;
ACS Biomaterials Science & Engineering, 2, 1905−1913; Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform.
The Linhardt Research Labs.; The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS);
The Linhardt Research Labs Online Collection; Rensselaer Polytechnic Institute, Troy, NY; ACS Biomaterials Science and Engineering; https://harc.rpi.edu/;